This suggests a metabolic adaptation in obesity where stress‐related pathways compensate for impaired insulin signaling but concurrently drive sustained transcriptional reprogramming that exacerbates lipid accumulation and inflammation, fueling MASLD progression. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.